Effect of a Declined Plasma Concentration of Valproic Acid Induced by Meropenem on the Antiepileptic Efficacy of Valproic Acid

Chunping Gu,Yongfang Zhang,Fumiao Yuan,Kaibin Huang,Zhenzhou Lin,Qiong Chen,Yan Chen,Yongming Wu,Dongmei Wang,Shengnan Wang

DOI: https://doi.org/10.1002/jcla.25025

IF: 3.124

2024-04-04

Journal of Clinical Laboratory Analysis

Abstract:We retrospectively reviewed data of hospitalized patients who were diagnosed with status epilepticus or epilepsy between 2010 and 2019. In this study, the reduced plasma concentration of VPA induced by the co‐administration of MEPM did not affect the antiepileptic efficacy of VPA. This conclusion should be interpreted with caution and more research is warranted. Objective This study aimed to indicate whether a declined plasma concentration of valproic acid (VPA) induced by co‐administration of meropenem (MEPM) could affect the antiepileptic efficacy of VPA. Methods We retrospectively reviewed data of hospitalized patients who were diagnosed with status epilepticus or epilepsy between 2010 and 2019. Patients co‐administered VPA and MEPM during hospitalization were screened and assigned to the exposure group, while those co‐administerd VPA and other broad‐spectrum antibiotics were allocated to the control group. Results The exposure group and control group included 50 and 11 patients, respectively. With a similar dosage of VPA, the plasma concentration of VPA significantly decreased during co‐administration (24.6 ± 4.3 μg/mL) compared with that before co‐administration (88.8 ± 13.6 μg/mL, p

medical laboratory technology